Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Notes Payables (2016 - 2024)

Neuroone Medical Technologies (NMTC) has disclosed Notes Payables for 9 consecutive years, with $121896.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Notes Payables changed N/A year-over-year to $121896.0, compared with a TTM value of $121896.0 through Mar 2024, changed N/A, and an annual FY2023 reading of $129116.0, changed N/A over the prior year.
  • Notes Payables was $121896.0 for Q1 2024 at Neuroone Medical Technologies, down from $129116.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $129116.0 in Q3 2023 and bottomed at $121896.0 in Q1 2024.